Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02245308 · ClinicalTrials.gov registry record · Phase 4
Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 133
- Enrollment target
NCT02245308: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT02245308 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 133 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02245308, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 133 participants
- Enrollment target
Study Summary
The goal of this research study is to examine the effects of a treatment for helping homeless veterans who smoke to stop smoking. Participants in the study will be assigned to one of two study groups. Participants in the first group will be referred to the local Department of Veterans Affairs Medical Center's Smoking Cessation Clinic for treatment. Second group participants will receive a behavioral treatment designed to reward smokers for quitting and staying quit. These participants will also receive telephone counseling and medications for smoking cessation.
Primary Outcome
Smoking abstinence at six months will be measured by self-report and bio-verified by salivary cotinine (a by-product of nicotine found in saliva).
Interventions
- BEHAVIORAL Smoking cessation counseling
- DRUG Bupropion
- DRUG Nicotine Patches
- BEHAVIORAL mobile contingency management (mCM)
- DRUG Nicotine rescue method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2018-09-28 |
| Phase | Phase 4 |
What the finished NCT02245308 record still lists
NCT02245308 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 5 interventions - of which Smoking cessation counseling is the first listed.
NCT02245308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02245308 about?
NCT02245308 is a clinical study titled "Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers". The goal of this research study is to examine the effects of a treatment for helping homeless veterans who smoke to stop smoking. Participants in the study will be assigned to one of two study groups. Participants in the first group will be referred to the local Department of Veterans Affairs Medica...
What is the current status of trial NCT02245308?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 133 participants. The study started on 2014-10-01. Estimated completion is 2018-09-28.
What interventions are being tested in trial NCT02245308?
The interventions under investigation include: Smoking cessation counseling (BEHAVIORAL), Bupropion (DRUG), Nicotine Patches (DRUG), mobile contingency management (mCM) (BEHAVIORAL), Nicotine rescue method (DRUG).
Who is sponsoring clinical trial NCT02245308?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02245308's enrollment target sits among peer trials
133 610th of 2000 higher than 1,391 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI